Biotech · Private company · George Town, Grand Cayman, CA, US
Theravance Biopharma, Inc.
SEC CIK 0001583107
Track this companyFree. Adds Theravance Biopharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials253 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- AmpreloxetinePhase 3 · Symptomatic Neurogenic Orthostatic HypotensionClinicalTrials.gov · fetched Nov 12, 2026
- TD-1473 Dose APhase 3 · Ulcerative Colitis (UC)ClinicalTrials.gov · fetched Nov 12, 2026
- TD-1473 Dose BPhase 3 · Ulcerative Colitis (UC)ClinicalTrials.gov · fetched Nov 12, 2026
- TD-1473 Dose CPhase 3 · Ulcerative Colitis (UC)ClinicalTrials.gov · fetched Nov 12, 2026
- TD-0903Phase 2 · Acute Lung Injury (ALI) Associated With COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- TD-1473Phase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TD-9855Phase 2 · Attention-Deficit/Hyperactivity DisorderClinicalTrials.gov · fetched Nov 12, 2026
- TD-9855Phase 2 · Neurogenic Orthostatic HypotensionClinicalTrials.gov · fetched Nov 12, 2026
- TD-9855 Group 1Phase 2 · FibromyalgiaClinicalTrials.gov · fetched Nov 12, 2026
- TD-9855 Group 2Phase 2 · FibromyalgiaClinicalTrials.gov · fetched Nov 12, 2026
- RevefenacinChronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TiotropiumChronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Nebulizer Versus Handheld Maintenance Therapy for Patients With COPDPHASE4 · RECRUITING · started Jul 14, 2026ClinicalTrials.gov NCT07816835 · fetched Nov 12, 2026
- Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting BronchodilatorsPHASE4 · RECRUITING · started Dec 5, 2023ClinicalTrials.gov NCT07133880 · fetched Nov 12, 2026
- Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophyPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 27, 2023ClinicalTrials.gov NCT05696717 · fetched Nov 12, 2026
- Phase 4 COPD and Suboptimal Inspiratory Flow RatePHASE4 · COMPLETED · started Jan 7, 2022ClinicalTrials.gov NCT05165485 · fetched Nov 12, 2026
- Revefenacin in Acute Respiratory Insufficiency in COPDPHASE2 · COMPLETED · started Nov 1, 2020ClinicalTrials.gov NCT04315558 · fetched Nov 12, 2026
- TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) StudyPHASE2_PHASE3 · TERMINATED · started Jul 23, 2020ClinicalTrials.gov NCT03920254 · fetched Nov 12, 2026
- TD-0903 for ALI Associated With COVID-19PHASE2 · COMPLETED · started Jun 24, 2020ClinicalTrials.gov NCT04402866 · fetched Nov 12, 2026
- Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailurePHASE3 · TERMINATED · started Sep 19, 2019ClinicalTrials.gov NCT04095793 · fetched Nov 12, 2026
- Efficacy & Safety of TD-1473 in Ulcerative ColitisPHASE2_PHASE3 · TERMINATED · started Mar 11, 2019ClinicalTrials.gov NCT03758443 · fetched Nov 12, 2026
- Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailurePHASE3 · TERMINATED · started Feb 22, 2019ClinicalTrials.gov NCT03829657 · fetched Nov 12, 2026
- Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic FailurePHASE3 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT03750552 · fetched Nov 12, 2026
- Efficacy and Safety of TD-1473 in Crohn's DiseasePHASE2 · TERMINATED · started Nov 19, 2018ClinicalTrials.gov NCT03635112 · fetched Nov 12, 2026
- TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)PHASE2 · COMPLETED · started Sep 9, 2017ClinicalTrials.gov NCT02705755 · fetched Nov 12, 2026
- A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)PHASE2 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02040792 · fetched Nov 12, 2026
- A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)PHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02109172 · fetched Nov 12, 2026
- Phase 2 Study of TD-9855 to Treat FibromyalgiaPHASE2 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01693692 · fetched Nov 12, 2026
- TD-1211 Single-Dose Study in Elderly and Young Healthy SubjectsPHASE1 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01655771 · fetched Nov 12, 2026
- A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211PHASE1 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01568411 · fetched Nov 12, 2026
- A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)PHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01458340 · fetched Nov 12, 2026
- Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly SubjectsPHASE1 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01467726 · fetched Nov 12, 2026
- A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced ConstipationPHASE2 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01459926 · fetched Nov 12, 2026
- A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)PHASE2 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01401985 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced ConstipationPHASE2 · COMPLETED · started May 1, 2011ClinicalTrials.gov NCT01333540 · fetched Nov 12, 2026
- A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced ConstipationPHASE1_PHASE2 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01040637 · fetched Nov 12, 2026
- Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)PHASE2 · COMPLETED · started Oct 1, 2006ClinicalTrials.gov NCT00391820 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Sep 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 18, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 25, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 23, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026